Immune Response Clinical Trial
Official title:
Snack Foods and Their Impact on Immune Optimisation to the Influenza Vaccination: a Randomised Controlled Trial of a Vaccination Model of Immune Response
The purpose of this study is to evaluate the impact of replacing usual snacks with alternative snack foods on the immune response to influenza vaccination in a population of healthy, middle-aged adults.
Nutrition plays an important role in the immune system by providing energy and metabolites to support the function of immune cells, allowing them to initiate effective immune responses. Diet is therefore a modifiable factor in impacting immune function and is currently a topic of substantial interest in health research. Snack consumption has been shown to account for approximately 20-30% of daily energy intake in adults. Therefore, snack choices have the potential to influence dietary intake and quality, and therefore immune function, both positively and negatively. This study assesses the effect of replacing usual snacks with alternative snack foods on the immune response in a model of viral infection - the seasonal influenza vaccine containing four prevalent influenza virus strains for the 2022/23 or 2023/24 influenza season, as determined by the World Health Organization. This study is a parallel group, randomised controlled trial that will examine the replacement of usual snack foods with alternative snack foods on the immune response to seasonal influenza vaccination in humans, which will be assessed by measuring rates of seroconversion, and other immunological markers following vaccination. The intervention will be for 8 weeks, and influenza vaccination will be administered at 4-week midpoint. Participants will be followed up 3 months post-vaccination to assess incidence of upper respiratory symptoms. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02872311 -
Open-Label Influenza Vaccine Evaluation
|
N/A | |
| Completed |
NCT01861613 -
Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
|
Phase 4 | |
| Completed |
NCT03982069 -
Immunologic Response to FluMist vs. Flucelvax
|
Phase 4 | |
| Recruiting |
NCT06041867 -
Agaricus Bisporus and Influenza Vaccination Response
|
N/A | |
| Completed |
NCT03614975 -
Immunologic Response to Influenza Vaccination in Children and Adolescents
|
Phase 4 | |
| Completed |
NCT04573543 -
The Role of Immune Semaphorins in NAFLD
|
||
| Recruiting |
NCT03875703 -
Post-Vaccination Biological Collection
|
||
| Completed |
NCT00902278 -
Immune Responses Induced by Different Licensed Influenza Vaccines
|
N/A | |
| Completed |
NCT00346619 -
Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults
|
Phase 1 | |
| Recruiting |
NCT04274348 -
Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum
|
N/A | |
| Active, not recruiting |
NCT05534893 -
Effect of Blueberries on Immunity and Response to Flu Vaccination
|
N/A | |
| Completed |
NCT05970887 -
Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines
|
Phase 4 | |
| Completed |
NCT05706350 -
Plant Stanol Esters and Influenza Vaccination
|
N/A | |
| Completed |
NCT03167593 -
Effects of Lactobacillus Coryniformis CECT5711 on Immune Response to Influenza Vaccination in Adults Over 65.
|
Phase 2 | |
| Completed |
NCT04386408 -
Evaluation of the Effect of a Combination of Plant Extracts (BSL_EP027) on the Incidence of Respiratory Infections
|
Phase 1 | |
| Completed |
NCT02933931 -
Immune Durability After VSV-EBOV Vaccination
|
||
| Recruiting |
NCT01289535 -
Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 Years
|
Phase 4 | |
| Active, not recruiting |
NCT02441426 -
Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development
|
N/A | |
| Recruiting |
NCT03399357 -
Evaluation of Metabolic Predictors of Influenza Vaccine Immune Response in the Singapore Elderly Population - the DYNAMIC Trial
|
N/A | |
| Active, not recruiting |
NCT05852964 -
Inflammatory and Anti-Inflammatory Gene Expressions in Liver Transplant Patients
|